Clinical Trials Logo

Primary CNS Lymphoma clinical trials

View clinical trials related to Primary CNS Lymphoma.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04073147 Terminated - Clinical trials for Primary CNS Lymphoma

Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma

VENOBI-CNS
Start date: May 12, 2020
Phase: Phase 1
Study type: Interventional

This is a phase IB study investigating the pharmacokinetics of the combination venetoclax and obinutuzumab in the cerebrospinal fluid of patient with relapsed primary CNS lymphoma.